乳酸菌活载体疫苗研究进展

摘要/Abstract

摘要： 乳酸菌以其益生性、佐剂效应、制备简单及生产成本低等优点被广泛用于各种病原抗原的传递载体研究。乳酸菌活载体疫苗能同时激发机体的体液免疫、黏膜免疫和细胞免疫反应，是目前疫苗研究领域的一个热点。作者分别对乳酸菌活载体疫苗的作用机理、传递外源抗原的形式进行概括，对其在预防各种病毒性、细菌性和寄生虫性等疾病的研究进行综述，并对其存在的问题、应用前景进行分析和展望。

关键词: 乳酸菌; 活载体; 疫苗; 黏膜免疫

Abstract: Lactic acid bacteria have been widely used as the vehicle to deliver various pathogen antigens for their advantage, such as probiotic, adjuvant effect, simple preparation, and low production cost. Live vaccine with lactic acid bacteria as the delivery vector is now one hot vaccine research field, for they can stimulate the humoral, mucosal, and cellular immune responses at the same time. In this paper, the mechanism and the way to deliver heterogenous antigen of this kind of live vaccine were generalized, the application of them in preventing viral, bacterial, and parasitic diseases was discussed, and the existed problem and prospect in application were finally analyzed and forecasted.

Key words: lactic acid bacteria; live vector; vaccine; mucosal immune

中图分类号:

Q939.9

曹海鹏, 王红宁, 张安云, 杨鑫, 马炳存, 徐鹏卫, 丁梦蝶. 乳酸菌活载体疫苗研究进展[J]. 中国畜牧兽医, 2014, 41(9): 258-264.

CAO Hai-peng, WANG Hong-ning, ZHANG An-yun, YANG Xin, MA Bing-cun, XU Peng-wei, DING Meng-die. Research Progress of Lactic Acid Bacteria as Live Vaccine Vehicle[J]. , 2014, 41(9): 258-264.

参考文献

1 于晨龙,张七斤,陈光明,等. 不同来源乳酸菌的分离与鉴定[J]. 中国畜牧兽医,2014,41(2):208～212.

2 王振华. 动物黏膜免疫疫苗基因表达系统——乳酸菌的研究进展[J]. 中国畜牧兽医,2010,37(10):194～197.

3 叶丽萍,郝凤奇,王春凤,等. 口服猪A组轮状病毒Vp4基因工程乳酸菌对BALB/c小鼠的免疫保护作用[J]. 中国兽医学报,2010,30(7):869～872.

4 任贵强,张七斤,张和平,等. 饲喂乳酸菌对小鼠血清中IgG及肠道sIgA影响的研究[J]. 中国畜牧兽医,2006,33(5):64～67.

5 孙建和,路平. 禽细胞因子的新功能——免疫治疗和疫苗佐剂[J]. 生物工程学报,2003,19(2):141～146.

6 齐炳理,葛俊伟,乔薪瑗,等. 表达传染性腔上囊病毒VP2蛋白重组乳酸菌疫苗的构建及其免疫保护效果[J]. 中国兽医科学,2009,39(11):978～983.

7 汪川,张朝武. 以益生菌为载体的基因工程疫苗研究进展[J]. 卫生研究,2008,37(1):118～122.

8 阿木尔吉日嘎拉,任贵强,张七斤,等. 两株乳酸菌对鸡新城疫HI抗体效价影响的研究[J]. 中国畜牧兽医,2006,33(3):62～64.

9 胡静涛,王春凤. 猪源A组轮状病毒重组质粒pW425et-Vp7在乳酸菌中的表达及免疫原性分析[J]. 微生物学报,2008,48(11):1514～1519.

10 饶雷,黄武,黄永兴,等. 弯曲杆菌中具有高抑菌活性乳酸菌的筛选[J]. 中国畜牧兽医,2013,40(6):129～134.

11 高荣琨,王昕,李文斌. 乳酸菌对及鸡免疫功能的影响[J]. 中国动物检疫,2009,26(12):39～40.

12 温建新,邵峰,李志辉,等. 乳酸菌制剂对鸡新城疫HI抗体效价影响的研究[J]. 山东畜牧兽医,2007,23(2):22～24.

13 黎敏,符海英. 细胞因子在畜禽疾病防治中的研究进展[J]. 广东农业科学,2010,4(2):201～204.

14 Amit-Romach E, Sklan D, Uni Z. Microflora ecology of the chicken intestine using 16S ribosomal DNA primers[J]. Poultry Sci, 2004, 83(7): 1093～1098.

15 Bermúdez-Humarán L G, Langella P, Cortes-Perez N G, et al. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production[J]. Infect Immunity, 2003, 71(4): 1887～1896.

16 Bermúdez-Humarán L G, Cortes-Perez N G, Lefèvre F, et al. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors[J]. J Immunol, 2005, 175(11): 7297～7302.

17 Bermúdez-Humarán L G. Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins[J]. Human Vaccines, 2009, 5(4): 264～267.

18 Bermúdez-Humarán L G, Kharrt P, Chatel J M, et al. Lactococci and Lactobacilli as mucosal delivery vector for therapeutic proteins and DNA vaccines[J]. Mcirobial Cell Factories, 2011, 10(1): S4.

19 Cao H P, Wang H N, Zhang A Y, et al. Expression of avian infectious bronchitis virus multi-epitope based peptide EpiC in Lactococcus lactis for oral immunization of chickens[J]. Biosci Biotechnol Biochem, 2012, 76(10): 1871～1876.

20 Cao H P, Wang H N, Yang X, et al. Lactococcus lactis anchoring avian infectious bronchitis virus multi-epitope peptide EpiC induces specific immune responses in chickens[J]. Biosci Biotechnol Biochem, 2013, 77(7): 1～6.

21 Cheung Q C K, Yuan Z F, Dyce P W, et al. Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice[J]. Am J Clin Nutr, 2009, 89(3): 871～879.

22 Cortes-Perez N G, da Costa-Medina L F, Lefèvre F, et al. Production of biologically active CXC chemokines by Lactococcus lactis: Evaluation of its potential as a novel mucosal vaccine adjuvant[J]. Vaccine, 2008, 26(46): 5778～5783.

23 Dieye Y, Hoekman A J W, Clier F, et al. Ability of Lactococcus lactis to export viral capsid antigens: A crucial step for development of live vaccines[J]. Appl Environ Microbiol, 2003, 69(12): 7281～7288.

24 Guimaraes V D, Gabriel J E, Lefevre F, et al. Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells[J]. Microbes Infect, 2005, 7(5): 836～844.

25 Hou X L, Yu L Y, Liu J Z, et al. Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria[J]. Vaccine, 2007, 26(1): 24～31.

26 Hugentobler F, Roberto R B D, Gillard J, et al. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection[J]. Vaccine, 2012a, 30 (39): 5726～5732.

27 Hugentobler F, Yam K K, Gillard J, et al. Immunization against Leishmania major infection using LACK- and IL-12-expresing Lactococcus lactis induces delay in footpad swelling[J]. PLoS One, 2012b, 7(2): e30945.

28 Innocentin S, Guimaraes V, Miyoshi A, et al. Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells[J]. Appl Environ Microbiol, 2009, 75(14): 4870～4878.

29 Kajikawa A, Satoh E, Leer R J, et al. Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis[J]. Vaccine, 2007, 25(18): 3599～3605.

30 Kajikawa A, Zhang L, Long J, et al. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica Serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery[J]. Clin Vaccine Immunol, 2012, 19(9): 1374～1381.

31 Lee M H, Roussel Y, Wilks M. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H.pylori infection in mice[J]. Vaccine, 2001, 19(28): 3927～3935.

32 Lee J S, Poo H, Han D P, et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice[J]. J Virol, 2006, 80(8): 4079～4087.

33 Lei H, Xu Y H, Chen J, et al. Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules[J]. Virol, 2010, 407(2): 319～324.

34 Li X, Xing Y, Guo L, et al. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice[J]. Pathog Dis, 2014, DOI: 10.1111/2049-632X. 12173.

35 Lin K H, Hsu A P, Shien J H, et al. Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria[J]. Vaccine, 2012, 30(33): 5019～5029.

36 Liu J K, Hou X L, Wei C H, et al. Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein[J]. Appl Environ Microbiol, 2009, 75(13): 4491～4497.

37 Loir Y L, Nouaille S, Commissaire J, et al. Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis[J]. Appl Environ Microbiol, 2001, 67(9): 4119～4127.

38 Loir Y L, Azevedo V, Oliveira S. Protein secretion in Lactococcus lactis: An efficient way to increase the overall heterologous protein production[J]. Microbial Cell Fact, 2005, 4: 2.

39 Matthijs M G R, Ariaans M P, Dwars R M, et al. Course of infection and immune responses in the respiratory tract of IBV infected broilers after superinfection with E. coli[J]. Vet Immunol Immunopathol, 2008, 127(1): 77～84.

40 Messaoudi S, Kergourlay G, Dalgalarrondo M, et al. Purification and characterization of a new bacteriocin active against camplybacter produced by Lactobacillus salivarius SMXD51[J]. Food Microbiol, 2012, 32(1): 129～134.

41 Moal V L, Servin A L. Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: From probiotics to gastrointestinal anti-infectious biotherapeutic agents[J]. Clin Microbiol Rev, 2014, 27(2): 167～199.

42 Moeini H, Rahim R A, Omar A R, et al. Lactobacillus acidophilus as a live vehicle for oral immunization against chicken anemia virus[J]. Appl Microbiol Biotechnol, 2011, 90: 77～88.

43 Moorthy G, Ramasamy R. Mucosal immunization of mice with malaria protein on lactic acid bacterial cell walls[J]. Vaccine, 2007, 25(18): 3636～3645.

44 Pathangey L, Kohler J J, Isoda R, et al. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines[J]. Vaccine, 2009, 27(20): 2707～2711.

45 Perez C A, Eichwald C, Burrone O, et al. Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice[J]. J Appl Mcrobiol, 2005, 99(5): 1158～1164.

46 Poo H, Pyo H M, Lee T Y, et al. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice[J]. Int J Cancer, 2006, 119(7): 1702～1709.

47 Qiao X Y, Li G W, Wang X Q, et al. Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice[J]. BMC Microbiol, 2009, 9: 249.

48 Ramasamy R, Yasawardena S, Zomer A. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunizations[J]. Vaccine, 2006, 24(18): 3900～3908.

49 Ribeiro L A, Azevedo V, Le Loir Y, et al. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: A first step towards food-grade live vaccines against Brucellosis[J]. Appl Environ Microbiol, 2002, 68(2): 910～916.

50 Sim A C N, Lin W W, Tan G K X, et al. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain Ⅲ antigen[J]. Vaccine, 2008, 26(9): 1145～1154.

51 Stephenson D P, Moore R J, Allison G E. Transformation of, and heterologous protein expression in, Lactobacillus agilis and Lactobacillus vaginalis isolates from the chicken gastrointestinal tract[J]. Appl Environ Microbiol, 2011, 77(1): 220～228.

52 Taheri H, Moravej H, Tabandeh F, et al. Screening of lactic acid bacteria toward their selection as a source of chicken probiotic[J]. Poultry Sci, 2009a, 88: 1586～1593.

53 Taheri H, Tabandeh F, Moravej H, et al. Potential probiotic of Lactobacillus johnsonii LT171 for chicken nutrition[J]. Afri J Biotechnol, 2009b, 8(21): 5838～5837.

54 Villena J, Medina M, Vintini E, et al. Stimulation of respiratory immunity by oral administration of Lactococcus lactis[J]. Can J Microbiol, 2008, 54(8): 630～638.

55 Wang Z S, Gao J K, Yu Q H, et al. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses[J]. Future Microbiol, 2012a, 7(8): 1003～1010.

56 Wang Z S, Yu Q H, Gao J K, et al. Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1[J]. Clin Vaccine Immunol, 2012b, 19(2): 174.

57 Wells J M, Wilson P W, Norton P M, et al. Lactococcus lactis: High-level expression of tetanus toxin fragment C and protection against lethal challenge[J]. Mol Microbiol, 1993, 8(6): 1155～1162.

58 Wu C Y, Yang G, Bermúdez-Humarán L G, et al. Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice[J]. Int Immunopharmacol, 2006, 6(4): 610～615.

59 Xin K Q, Hoshino Y, Toda Y. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env[J]. Immunol, 2003, 102(1): 223～228.

60 Xu Y G, Li Y J. Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization[J]. Immunol, 2007, 124(1): 68～75.

61 Yang S, Li W, Challis J R, et al. Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice[J]. Am J Obstet Gynecol, 2014, 211(1):44.e1~44.e12.

62 Zhang Y, Wang H N, Wang T, et al. Complete genome sequence and recombination analysis of infectious bronchitis virus attenuated vaccine strain H120[J]. Virus Genes, 2010, 41(3): 377～388.

[1]	韩冰, 汤思淇, 朱大帷, 李海玲, 冯亚莉, 苏超凡, 徐艺娜, 冷昊钰, 王永涛, 张月美, 太晓春, 张莹. 新型疫苗佐剂研究进展[J]. 中国畜牧兽医, 2023, 50(6): 2460-2467.
[2]	余新刚, 袁凯健, 穆宣儒, 王红彩, 戚南山, 张浩吉. 贾第虫包囊壁形成及囊壁蛋白研究进展[J]. 中国畜牧兽医, 2023, 50(5): 2061-2068.
[3]	陈天宝, 王娅妮, 刘宝玲, 王刚, 王晓虎, 柳旭辉, 蔡汝健, 贺东生. 中药抗猪繁殖与呼吸综合征病毒的作用机制研究进展[J]. 中国畜牧兽医, 2023, 50(5): 2114-2129.
[4]	陈吉敏, 李辉煌, 赖连杰, 杨银华, 杨悦, 林瑞意. 鸭坦布苏病毒检测方法及疫苗研究进展[J]. 中国畜牧兽医, 2023, 50(4): 1329-1339.
[5]	陈少俊, 李刚, 奈子达, 刘娣, 姜新鹏. 基因编辑益生菌在动物肠道健康上的研究及应用[J]. 中国畜牧兽医, 2023, 50(3): 1016-1024.
[6]	刘新月, 栗利芳, 王振豹, 张文亮, 张欣, 赵洪涛, 李鹏宇, 郑昊天, 肖进, 齐鹏. 猪圆环病毒2型合成肽疫苗佐剂筛选与免疫保护性研究[J]. 中国畜牧兽医, 2023, 50(3): 1068-1080.
[7]	刘馨, 潘吉脉, 胡安东, 曾成容, 杨颖, 程振涛, 陈江凤, 姜海波, 文明. 黄芪多糖对杂交鲟用嗜水气单胞菌灭活疫苗的影响[J]. 中国畜牧兽医, 2023, 50(3): 1177-1184.
[8]	刘珍妮, 雷小文, 李建军, 曾庆远, 谭东海, 钟云平, 张强, 谢华亮. 发酵脐橙粕对番鸭肠道形态结构、肠黏膜免疫功能和微生物多样性的影响[J]. 中国畜牧兽医, 2023, 50(2): 573-585.
[9]	李琦, 田野, 黄涛, 刘存霞. 纳米疫苗在禽流感防控中的研究进展[J]. 中国畜牧兽医, 2023, 50(2): 684-692.
[10]	刘颖, 田旭, 冯晓梦, 吕晓萍, 高雪丽, 郑世民, 刘超男. 黄芪多糖对肠炎雏鸡小肠黏膜损伤的保护作用[J]. 中国畜牧兽医, 2023, 50(1): 76-85.
[11]	徐景峨, 李婷, 陈汝佳, 余波, 张亚楠, 杨莉, 赵滨, 蒲龄. 鸭疫里氏杆菌二价灭活疫苗制备及免疫效力研究[J]. 中国畜牧兽医, 2023, 50(1): 290-299.
[12]	刘宏莹, 王婧瑜, 崔珍珍, 马青霞, 汪婷婷, 李健明, 时坤, 宫庆龙, 杜锐, 冷雪. 中药有效成分对动物疫苗的免疫佐剂效果及相关机理研究进展[J]. 中国畜牧兽医, 2023, 50(1): 390-397.
[13]	赵逢淼, 郭婷, 周雅坪, 赵红梅, 王宇琛, 田广原, 孙雅婕, 卞宇晨, 于佳梁, 郝永清. 牛病毒性腹泻病毒对新西兰白兔致病性分析及E2蛋白免疫效果的评价[J]. 中国畜牧兽医, 2022, 49(9): 3549-3558.
[14]	贾新月, 马静, 张艳艳, 马勋, 王正荣, 薄新文. 动物寄生虫口服疫苗研究进展[J]. 中国畜牧兽医, 2022, 49(9): 3569-3580.
[15]	徐娅玲, 张霁辉, 牛熙, 李升, 黄世会, 冉雪琴, 王嘉福. 非洲猪瘟病毒P72蛋白合成肽疫苗的构建及其免疫效力评估[J]. 中国畜牧兽医, 2022, 49(8): 3083-3090.